Eton Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q3 2024.
  • Eton Pharmaceuticals, Inc. Interest Expense for the quarter ending September 30, 2024 was $211K, a 21% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Interest Expense for 2023 was $1.06M, a 11% increase from 2022.
  • Eton Pharmaceuticals, Inc. annual Interest Expense for 2022 was $955K, a 8.35% decline from 2021.
  • Eton Pharmaceuticals, Inc. annual Interest Expense for 2021 was $1.04M, a 17.9% increase from 2020.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $211K -$56K -21% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q1 2024 $238K -$27K -10.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $267K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q1 2023 $265K +$18K +7.29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $247K -$17K -6.44% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $264K +$69K +35.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $195K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.